Building Omaha’s Medtech Infrastructure
At the intersection of university innovation and market impact, UNeTech has established itself as a catalyst for medical technology development in Omaha. Through the Omaha Medical Technology Development Alliance, the Omaha Medical Technology Pipeline, and UNeTech Deploy!, all Economic Development Administration-funded initiatives, UNeTech has created a foundation for MedTech growth that supports startups from conception to commercialization. This infrastructure approach is particularly evident in how UNeTech has fostered the development of companies like MicroWash and Precision Syringe.
The challenge of translating university research into commercial success is significant in the medical technology sector. Necessity breeds collaboration in this environment: creating shared resources, mentorship opportunities, and capital connections that allow multiple startups to develop simultaneously. With Nebraska’s support and strategic collaborations, UNeTech has maximized capital efficiency, stretching investment dollars further than would be possible in coastal tech hubs.
MicroWash and Precision Syringe: Collaborative Innovation
MicroWash exemplifies how startups can thrive within UNeTech’s ecosystem. Similarly, Precision Syringe has leveraged UNeTech’s resources to advance its innovative medical device technology. Together these companies have raised nearly $2M.
What makes these companies particularly noteworthy is how they’ve developed in parallel, benefiting from shared resources and knowledge within the UNeTech framework. By leveraging Omaha’s supply chain and sharing key professional resources, the two companies have supported one another through collaborative necessity. This co-development has created synergies that wouldn’t be possible in isolation. By sharing expertise in regulatory navigation, manufacturing processes, and investor connections, both companies have accelerated their paths to market while maintaining capital efficiency.
The results speak for themselves. As part of UNeTech’s portfolio, these companies contribute to the impressive $3.1M raised across multiple startups in 2024 alone. This achievement demonstrates how UNeTech’s infrastructure approach creates a multiplier effect, where each investment dollar supports more than a single company, but a resilient innovation ecosystem.
The Midwest Advantage
The capital efficiency of UNeTech’s model highlights a distinct Midwest advantage in MedTech development. Unlike coastal innovation hubs where overhead costs consume significant portions of investment capital, Omaha offers an environment where funding goes further. This advantage translates directly to investor returns and sustainable company growth. Necessity breeds collaboration as companies must work together and do more with less simply to launch.
Beyond financial benefits, UNeTech’s approach creates lasting economic impact. By sharing technical and industrial resources, the ecosystem builds momentum that attracts additional innovators and investors. The result is a sustainable innovation pipeline that strengthens with each successful startup.
The Future of Midwest Medtech
UNeTech’s work with companies like MicroWash and Precision Syringe has created a blueprint for efficient MedTech development that challenges traditional innovation models. As these companies continue to grow, they validate Omaha’s position as an emerging MedTech hub worth watching.
For investors seeking opportunities in the MedTech sector, UNeTech’s ecosystem offers access to capital-efficient startups with strong university connections and established support infrastructure. The success of MicroWash and Precision Syringe demonstrates that where necessity breeds collaboration, groundbreaking medical innovation isn’t limited to coastal tech hubs—it’s thriving in America’s heartland.
